Morning Overview on MSN
The FDA just cleared Beqalzi for mantle cell lymphoma — sonrotoclax becoming the latest targeted therapy for a relapsed blood cancer with few options
Adults with mantle cell lymphoma who have already failed two or more treatments, including a BTK inhibitor, now have a new ...
A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted cancer drug selpercatinib can significantly reduce the risk of lung cancer returning ...
The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for ...
Dedifferentiated liposarcoma (DDLS) is a rare and aggressive soft tissue cancer with few effective treatment options. But now ...
Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...
Each type of cancer is unique, and there’s no one-size-fits-all treatment. Immunotherapy and targeted medications allow doctors to treat cancer using different approaches that help improve overall ...
Using patient-derived cardiac tissue and stem cell-based models, the team of translational researchers demonstrated that targeting the genetic cause of disease improved cellular abnormalities and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results